• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Protein PAT1 homolog 1 (PATL1)

ACP01946

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01946 Target NamePATL1
Target SynonymsPAT1-like protein 1;Protein PAT1 homolog b;Pat1b;hPat1bFormLiquid or Lyophilized powder
Expression SystemE.coliMol Weight89.6 kDa
Protein LengthFull lengthPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ86TB9
Background Information
  • Uniprot Id

    Q86TB9

  • Target Species

    Human

  • Target Name

    PATL1

  • Target Full Name

    Protein PAT1 homolog 1

  • Target Function

    RNA-binding protein involved in deadenylation-dependent decapping of mRNAs, leading to the degradation of mRNAs. Acts as a scaffold protein that connects deadenylation and decapping machinery. Required for cytoplasmic mRNA processing body (P-body) assembly.; (Microbial infection) In case of infection, required for translation and replication of hepatitis C virus (HCV).

  • Target Subcellular Location

    Cytoplasm, P-body. Nucleus. Nucleus, PML body. Nucleus speckle.

  • Target Protein Families

    PAT1 family

  • Target Tissue Specificity

    Ubiquitous.

  • Target Research Area

    Epigenetics and Nuclear Signaling

  • Target Synonyms

    hPat1b; OK/KNS-cl.5; PAT1-like protein 1; Pat1b; PATL1; PATL1_HUMAN; protein associated with topoisomerase II homolog 1 ; Protein PAT1 homolog 1; Protein PAT1 homolog b

Inquire Recombinant Human Protein PAT1 homolog 1 (PATL1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification